Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly

Leukemia and Lymphoma

Volumn 50, Issue 3, 2009, Pages 335-340

  Wong, Hannah H ^a   Wang, Jun ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DLBCL; EBV; Elderly

Indexed keywords

ANTINEOPLASTIC AGENT; CD15 ANTIGEN; CD20 ANTIGEN; CD30 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPSTEIN BARR VIRUS ANTIGEN 2; KI 67 ANTIGEN; LATENT MEMBRANE PROTEIN 1; PREDNISONE; PROTEIN BCL 6; RITUXIMAB; TRANSCRIPTION FACTOR PAX5; VINCRISTINE;

B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG RESPONSE; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LABORATORY TEST; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TUMOR DIFFERENTIATION;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED;

EID: 67650892412     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902725813     Document Type: Review

References (22)

1. Oyama, T., Ichimura, K., Suzuki, R., Suzumiya, J., Ohshima, K. Yatabe, Y. et al. (2003) Senile EBV+ B-cell lymphoproliferative disorders: A clinicopathologic study of 22 patients. Am J Surg Pathol, 27, pp. 16-26.
2. Nakamura, S., Jaffe, E. S. and Swerdlow, S. H. (2008) EBV+ diffuse large B-cell of the elderly. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, pp. 243-244. IARC, Lyon, France
3. Oyama, T., Yamamoto, K., Asano, N., Oshiro, A., Suzuki, R. Kagami, Y. et al. (2007) Age-related EBV-associated B-Cell lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients. Clin Cancer Res, 13, pp. 5124-5132.
4. Lages, C. S., Suffia, I., Velilla, P. A., Huang, B., Warshaw, G. Hildeman, D. A. et al. (2008) Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol, 181, pp. 1835-1848.
5. de Sanjose, S., Bosch, R., Schouten, T., Verkuijlen, S., Nieters, A. Foretova, L. et al. (2007) Epstein-Barr virus infection and risk of lymphoma: Immunoblot analysis of antibody responses against EBV-related proteins in a large series of lymphoma subjects and matched controls. Int J Cancer, 121, pp. 1806-1812.
6. Shimoyama, Y., Yamamoto, K., Asano, N., Oyama, T., Kinoshita, T. and Nakamura, S. (2008) Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: Special references in lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci, 99, pp. 1085-1091.
7. Shimoyama, Y., Oyama, T., Asano, N., Oshiro, A., Kinoshita, T. Nakamura, S. et al. (2006) Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: A mini review. J Clin Exp Hematopathol, 46, pp. 1-4.
8. Thompson, M. P. and Kurzrock, R. (2004) Epstein-Barr virus and cancer. Clin Cancer Res, 10, pp. 803-821.
9. Park, S., Lee, J., Ko, Y. H., Han, A., Jun, H. J. Lee, S. C. et al. (2007) The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood, 110, pp. 972-978.
10. Kapatai, G. and Murray, P. (2007) Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol, 60, pp. 1342-1349.
11. Carbone, A., Gloghini, A. and Dotti, G. (2008) EBV-Associated lymphoproliferative disorders: Classification and treatment. Oncologist, 13, pp. 577-585.
12. Jarrett, R. F., Stark, G. L., White, J. W., Angus, B., Alexander, F. E. Krajewski, A. S. et al. (2005) Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study. Blood, 106, pp. 2444-2451.
13. Shimoyama, Y., Yamamoto, K., Asano, N., Oyama, T., Kinoshita, T. and Nakamura, S. (2008) Age- related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: Special references in lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci, 99, pp. 1085-1091.
14. Shiozawa, E., Saito, B., Yamochi-Onizuka, T., Makino, R., Takimoto, M. Nakamaki, T. et al. (2007) Senile EBV-associated B-cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma. Pathol Int, 57, pp. 688-693.
15. Takegawa, S., Jin, Z., Nakayama, T., Oyama, T., Hieshima, K. Nagakubo, D. et al. (2008) Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder. Cancer Sci, 99, pp. 296-302.
16. Mueller, S., Aigner, T., Haag, J., Schwartz, R. and Niedobitek, G. (2007) Senile EBV-associated B-cell lymphoproliferative disorder of prepatellar bursa in elderly patient with multifocal urate arthropathy. Hematol Oncol, 25, pp. 140-142.
17. Wright, D. H. (1997) What is Burkitt's lymphoma. J Pathol, 182, pp. 125-127.
18. Hamilton-Dutoit, S. J., Raphael, M., Audouin, J., Diebold, J., Lisse, I. Pedersen, C. et al. (1993) In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site. Blood, 82, pp. 619-624.
19. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC, Lyon, France
20. Chadburn, A., Chen, J. M., Hsu, D. T., Frizzera, G., Cesarman, E. Garrett, T. J. et al. (1998) The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer, 82, pp. 1978-1987.
21. Ghandi, M. K., Tellam, J. T. and Khanna, R. (2004) Epstein-Barr virus-associated Hodgkin lymphoma. Br J Haematol, 125, pp. 267-281.
22. Coiffier, B., Lepage, E., Brier, J., Herbrecht, R., Tilly, H. Bouabdallah, R. et al. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med, 346, pp. 235-242.